{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_interleukin_17_inhibitors",
          "name": "Interleukin-17 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_topical_corticosteroids",
          "name": "Topical corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H1"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Acitretin影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H2"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Apremilast影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H3"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Etanercept影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H4"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Infliximab影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H5"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Secukinumab影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H6"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Cyclosporine影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H7"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Methotrexate影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H8"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Adalimumab影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H9"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Interleukin-17 inhibitors影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H10"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Topical corticosteroids影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H11"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Ustekinumab影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 2.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "potential adverse effects",
              "pro": [
                "H12"
              ],
              "con": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Thalidomide影响炎症调节，与红斑性脓疱性银屑病的机制相符"
          ],
          "safety_risk": [
            "潜在风险可能抵消药物带来的益处"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_inflam_regulation",
          "type": "Target",
          "label": "Inflammatory Regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_psoriasis_pathway",
          "type": "Pathway",
          "label": "Psoriasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_acitretin_pathway",
          "type": "Pathway",
          "label": "Acitretin Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_apremilast_pathway",
          "type": "Pathway",
          "label": "Apremilast Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_il17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTargetR",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "RiskPathwayR",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "AdverseEffects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Thalidomide",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Acitretin已知对炎症调节的影响"
        },
        {
          "source": "drug_acitretin",
          "target": "p_acitretin_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Acitretin作用于特定通路"
        },
        {
          "source": "p_acitretin_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "drug_apremilast",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Apremilast已知对炎症调节的影响"
        },
        {
          "source": "drug_apremilast",
          "target": "p_apremilast_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Apremilast作用于特定通路"
        },
        {
          "source": "p_apremilast_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "drug_etanercept",
          "target": "t_inflam_regulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Etanercept已知对炎症调节的影响"
        },
        {
          "source": "drug_etanercept",
          "target": "p_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Etanercept作用于相关通路"
        },
        {
          "source": "p_psoriasis_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路调节与红斑性脓疱性银屑病的关联"
        },
        {
          "source": "n_acitretin",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在离靶作用可能引发风险"
        },
        {
          "source": "n_apremilast",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "机制尚不明确，可能引起不适"
        },
        {
          "source": "n_etanercept",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能涉及不良反应的靶点"
        },
        {
          "source": "n_infliximab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与免疫抑制相关的潜在风险"
        },
        {
          "source": "n_secukinumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "存在激活/抑制的争议"
        },
        {
          "source": "n_cyclosporine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Skeptic",
          "rationale": "监测肾脏安全性有必要"
        },
        {
          "source": "n_methotrexate",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "耐受性问题和并发症风险"
        },
        {
          "source": "n_adalimumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.68,
          "agent": "Skeptic",
          "rationale": "对某些患者免疫相关风险"
        },
        {
          "source": "n_il17_inhibitors",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能带来新型反应"
        },
        {
          "source": "n_topical_corticosteroids",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "长期用途的不良反应"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "已知免疫抑制效果需警惕"
        },
        {
          "source": "n_thalidomide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与致畸性及其他副作用的关联"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在风险通路的中介"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能引发多种不良效果"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险抵消药物收益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "score": 0.71,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "MOA→通路→表型链闭合",
          "安全性监测要求已识别"
        ],
        "caveats": [
          "潜在风险可能影响效果"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "score": 0.71,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "MOA→通路→表型链闭合",
          "安全性监测要求已识别"
        ],
        "caveats": [
          "潜在风险可能影响效果"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "score": 0.71,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "MOA→通路→表型链闭合",
          "安全性监测要求已识别"
        ],
        "caveats": [
          "潜在风险可能影响效果"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Inflammatory Regulation→Generalised Pustular Psoriasis",
          "reason": "机制闭环且有不相交备援路径"
        }
      ],
      "remaining_gaps": [
        "不同药物之间的安全性争议未解"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "补齐了通路 X，path_disjointness↑"
        },
        {
          "round": 2,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "安全性冲突仍高，建议剪枝"
        }
      ],
      "lessons": [
        "当机制连通性普遍缺失时，优先引入作用位点/通路不同的候选",
        "对长期由安全性主导的负面分值，需引入人群/PK 友好的替代类别"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "确保不同候选药物的机制和安全性数据的全面覆盖；优先构造不相交的机制路径。"
      },
      {
        "role": "Skeptic",
        "patch": "针对潜在风险给出可证伪的最小事实点，并用高权重 refutes 边显式标注。"
      },
      {
        "role": "Explorer",
        "patch": "关注机制与副作用间的整合；确保新引入的候选具备独特作用机制。"
      }
    ],
    "heuristics": [
      {
        "when": "血压相关表型",
        "then": "应考虑安全性监测与剂量调整，尤其是免疫抑制剂使用时"
      },
      {
        "when": "药物安全性分析",
        "then": "需特别关注对肾脏及肝脏的潜在影响"
      }
    ]
  }
}